Contents

Search

afatinib (Gilotrif)

Indications: - EGF receptor-positive non-small cell lung cancer [NGC, NICE] Dosage: - 40 mg PO QD (at least 1 hour before or 2 hours after meal) [2] Mechanism of action: - EGF receptor inhibitor

Interactions

drug adverse effects of tyrosine kinase inhibitor(s)

General

small inhibitory antineoplastic agent (ib drug) EGF receptor (EGFR) inhibitor

Database Correlations

PUBCHEM correlations

References

  1. Medscape http://www.medscape.com
  2. Windle ML FDA Drug Approvals and Changes: May edition. Medscape. May 20, 2016 http://reference.medscape.com/features/slideshow/drug-review/2016/may